Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial

Published:2022-02 Issue:2 Volume:23 Page:234-247
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Kang Yoon-Koo,Chen Li-Tzong,Ryu Min-Hee,Oh Do-Youn,Oh Sang Cheul,Chung Hyun Cheol,Lee Keun-Wook,Omori Takeshi,Shitara Kohei,Sakuramoto Shinichi,Chung Ik-Joo,Yamaguchi Kensei,Kato Ken,Sym Sun Jin,Kadowaki Shigenori,Tsuji Kunihiro,Chen Jen-Shi,Bai Li-Yuan,Oh Sung-Yong,Choda Yasuhiro,Yasui Hisateru,Takeuchi Kentaro,Hirashima Yoshinori,Hagihara Shunsuke,Boku Narikazu

Funder

Bristol-Myers Squibb

Ono Pharmaceutical

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Smyth;Ann Oncol,2016

2. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology;Ajani;J Natl Compr Canc Netw,2016

3. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS;Muro;Ann Oncol,2019

4. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial;Kang;Ann Oncol,2009

5. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial;Koizumi;Lancet Oncol,2008

Cited by 389 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies in gastroesophageal tumors;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. CD19+CD73+ B cells infiltration indicates poor prognosis and unfavorable responses to immunotherapy in gastric cancer;International Immunopharmacology;2024-11

3. Surgical treatment for liver metastasis from gastric cancer: A systematic review and meta-analysis of long-term outcomes and prognostic factors;European Journal of Surgical Oncology;2024-10

4. Genomic biology and therapeutic strategies of liver metastasis from gastric cancer;Critical Reviews in Oncology/Hematology;2024-10

5. Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study;BMC Cancer;2024-09-09